|
FDASmart conducts symposium on "BioPharma IT-Next Generation: Will India Lead or Follow"
Our News Bureau - Mumbai
FDASmart recently concluded its one day conference on September
27, in Mumbai. This one day forum focused on how bio/pharmaceutical companies
are leveraging IT such as cloud computing, wireless mobility, new web collaboration
etc. to deliver innovative competitive efficiencies in drug development life
cycle starting including R&D, clinical trials, manufacturing and supply
chain.
The one-day event showcased first of a kind, innovative solutions,
best practices leveraging to information technology to get the business of pharma
to the next level. A group of world class speakers were assembled for the event
to address the IT role in enhancing the pharma drug business. All speakers from
the various stakeholder positions presented on the same theme but with their
unique prospective, a trademark strategy. Sudhakar Kasturi, business consultant-informatics,
Thermo Fisher Scientific covered the challenges in pharma workflows from early
discovery to batch release. According to him, each stage has its own set of
data management problems that need to deal with different tools specifically
configured for those workflows but enveloped within a system that ties it all
together. Thermo Fisher featured their "paperless LAB" as well.
 |
 |
He was followed by other speakers including Gopal Rangaraj,
chief information officer, Reliance Life Sciences who addressed the diversity
of biopharma business that necessitates provisioning of differentiated solution
to address. Arshad Mohammed director of Clinical Data Management at Quintiles
shared their innovative technology solution to manage the operations and risk
for hundreds of Quintiles CRO projects. Their unique system is in use across
all Quintiles global data management clinical trial sites. Quintiles unique
system features a high level dashboard then drill-down for more data fashion.
Also speaking were Sandeep Saxena, founder and chief executive officer, Acton
Biotech on IT role in genomics, Reena Gollapudy, lead consultant, Infosys shared
her view on key aspects of enterprise applications and solutions, such as cloud-based
offerings, SaaS, IaaS, PaaS models, solution architecture, data security, and
system integration while Neelesh Bhandari, chief consulting officer, Digital
MedCom on a provocative approach that we already have sufficient IT technologies,
and that the real issues dwell on how they are utilised. Harvinder Singh, chief
executive officer, Vsell Solutions/Intralinks Partner has presented on Intralinks
customised solutions for global as well as Indian pharma companies in use for
licensing, clinical trials and safety document distribution needs.
A lively panel discussion with audience participation followed
which was hosted by Dipta Chaudhury, senior consultant at Frost & Sullivan
India. Frost & Sullivan- the event Knowledge Partner along with FDASmart
Inc. released a joint white paper during the event.
|